Albacia, Analiza T.
HRN: 23-48-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
CEFUROXIME 1.5GM (VIAL)
09/02/2023
09/03/2023
IV
1.5g
Q8h
S/p Primary LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes